Short interest in 4D Molecular Therapeutics Inc (NASDAQ:FDMT) decreased during the last reporting period, falling from 9.49M to 8.18M. This put 16.31% of the company's publicly available shares short.

Short interest for 4D Molecular Therapeutics gives investors a sense of the degree to which investors are betting on the decline of 4D Molecular Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 741.55K shares traded per day, it would take 11.03 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.